JW Life Science Corp
KRX:234080
JW Life Science Corp
KRX:234080
Price:
12 780
KRW
2.4%
Market Closed
Market Cap:
₩202.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
JW Life Science Corp
KRX:234080
|
KR |
|
Sato Holdings Corp
TSE:6287
|
JP |
|
E
|
Emperor Capital Group Ltd
HKEX:717
|
HK |
|
F
|
Federal-Mogul Goetze (India) Ltd
NSE:FMGOETZE
|
IN |
|
UNQ Holdings Ltd
HKEX:2177
|
CN |
|
S
|
Sberbank Rossii PAO
LSE:SBER
|
RU |
|
GUD Holdings Ltd
ASX:GUD
|
AU |
|
D
|
Domiki Kritis SA
ATHEX:DOMIK
|
GR |
Income Statement
Earnings Waterfall
JW Life Science Corp
JW Life Science Corp
Income Statement
JW Life Science Corp
JW Life Science Corp
Currency: KRW
| Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
2 582
|
2 437
|
2 365
|
2 371
|
2 409
|
2 409
|
2 438
|
2 416
|
2 354
|
2 268
|
2 222
|
2 193
|
2 259
|
2 274
|
2 013
|
1 986
|
1 726
|
1 587
|
1 568
|
1 308
|
2 609
|
2 466
|
2 509
|
2 603
|
1 281
|
1 523
|
1 823
|
2 579
|
3 092
|
3 348
|
3 432
|
2 951
|
2 693
|
2 438
|
2 286
|
2 172
|
2 061
|
0
|
0
|
0
|
|
| Revenue |
125 950
N/A
|
130 257
+3%
|
129 223
-1%
|
129 096
0%
|
132 290
+2%
|
133 299
+1%
|
133 223
0%
|
139 233
+5%
|
143 600
+3%
|
148 330
+3%
|
151 388
+2%
|
154 069
+2%
|
155 230
+1%
|
156 834
+1%
|
161 965
+3%
|
164 795
+2%
|
170 221
+3%
|
175 938
+3%
|
181 526
+3%
|
184 768
+2%
|
183 521
-1%
|
180 975
-1%
|
176 140
-3%
|
170 038
-3%
|
169 817
0%
|
171 226
+1%
|
175 624
+3%
|
183 113
+4%
|
188 931
+3%
|
195 087
+3%
|
200 051
+3%
|
203 466
+2%
|
206 860
+2%
|
212 203
+3%
|
214 510
+1%
|
221 321
+3%
|
222 478
+1%
|
235 775
+6%
|
243 638
+3%
|
248 297
+2%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(95 746)
|
(97 712)
|
(96 271)
|
(94 288)
|
(98 012)
|
(98 734)
|
(97 874)
|
(103 108)
|
(106 420)
|
(112 805)
|
(114 947)
|
(116 470)
|
(115 715)
|
(113 629)
|
(116 523)
|
(117 615)
|
(121 616)
|
(124 742)
|
(127 551)
|
(128 467)
|
(124 024)
|
(122 935)
|
(120 480)
|
(117 825)
|
(120 660)
|
(123 062)
|
(127 872)
|
(135 727)
|
(140 810)
|
(145 310)
|
(149 730)
|
(151 881)
|
(154 467)
|
(159 045)
|
(160 387)
|
(164 723)
|
(164 970)
|
(174 447)
|
(177 315)
|
(179 429)
|
|
| Gross Profit |
30 204
N/A
|
32 543
+8%
|
32 952
+1%
|
34 809
+6%
|
34 278
-2%
|
34 566
+1%
|
35 349
+2%
|
36 125
+2%
|
37 180
+3%
|
35 526
-4%
|
36 442
+3%
|
37 600
+3%
|
39 515
+5%
|
43 205
+9%
|
45 442
+5%
|
47 180
+4%
|
48 605
+3%
|
51 196
+5%
|
53 975
+5%
|
56 301
+4%
|
59 497
+6%
|
58 041
-2%
|
55 661
-4%
|
52 214
-6%
|
49 157
-6%
|
48 164
-2%
|
47 752
-1%
|
47 386
-1%
|
48 121
+2%
|
49 776
+3%
|
50 321
+1%
|
51 584
+3%
|
52 393
+2%
|
53 157
+1%
|
54 123
+2%
|
56 598
+5%
|
57 508
+2%
|
61 328
+7%
|
66 323
+8%
|
68 868
+4%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(11 548)
|
(11 876)
|
(12 394)
|
(13 016)
|
(12 648)
|
(12 856)
|
(12 815)
|
(12 665)
|
(13 404)
|
(14 178)
|
(15 603)
|
(15 914)
|
(15 974)
|
(15 828)
|
(16 152)
|
(17 977)
|
(18 856)
|
(20 137)
|
(20 305)
|
(20 174)
|
(20 046)
|
(23 127)
|
(23 593)
|
(23 632)
|
(20 741)
|
(21 202)
|
(21 207)
|
(21 569)
|
(21 031)
|
(20 661)
|
(20 467)
|
(20 795)
|
(21 531)
|
(22 568)
|
(22 924)
|
(22 347)
|
(21 650)
|
(24 867)
|
(28 860)
|
(33 614)
|
|
| Selling, General & Administrative |
(10 786)
|
(11 045)
|
(11 519)
|
(12 089)
|
(11 583)
|
(11 837)
|
(11 781)
|
(11 701)
|
(12 561)
|
(13 239)
|
(14 425)
|
(14 570)
|
(14 206)
|
(13 924)
|
(13 411)
|
(14 147)
|
(14 234)
|
(14 229)
|
(14 007)
|
(13 749)
|
(13 598)
|
(13 283)
|
(13 501)
|
(13 365)
|
(13 199)
|
(13 725)
|
(13 354)
|
(13 650)
|
(13 639)
|
(13 466)
|
(14 259)
|
(14 825)
|
(15 302)
|
(16 517)
|
(16 805)
|
(16 747)
|
(16 820)
|
(19 490)
|
(22 727)
|
(26 514)
|
|
| Research & Development |
(399)
|
(473)
|
(498)
|
(536)
|
(665)
|
(602)
|
(606)
|
(524)
|
(399)
|
(488)
|
(717)
|
(855)
|
(1 249)
|
(1 310)
|
(1 991)
|
(2 922)
|
(3 583)
|
(4 762)
|
(5 058)
|
(5 219)
|
(5 195)
|
(4 972)
|
(5 224)
|
(5 385)
|
(6 242)
|
(6 171)
|
(6 212)
|
(6 289)
|
(5 737)
|
(5 558)
|
(4 956)
|
(4 768)
|
(5 161)
|
(5 073)
|
(5 229)
|
(4 779)
|
(4 030)
|
(4 415)
|
(4 504)
|
(5 038)
|
|
| Depreciation & Amortization |
(363)
|
(366)
|
(378)
|
(392)
|
(400)
|
(418)
|
(429)
|
(441)
|
(444)
|
(452)
|
(462)
|
(490)
|
(518)
|
(594)
|
(751)
|
(909)
|
(1 039)
|
(1 146)
|
(1 193)
|
(1 207)
|
(1 252)
|
(1 274)
|
(1 268)
|
(1 281)
|
(1 300)
|
(1 307)
|
(1 641)
|
(1 630)
|
(1 616)
|
(1 601)
|
(1 217)
|
(1 165)
|
(1 068)
|
(967)
|
(891)
|
(820)
|
(799)
|
(961)
|
(1 629)
|
(2 062)
|
|
| Other Operating Expenses |
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(47)
|
0
|
0
|
(3 599)
|
(3 600)
|
(3 601)
|
0
|
0
|
0
|
0
|
(40)
|
(36)
|
(36)
|
(36)
|
0
|
(11)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
18 656
N/A
|
20 668
+11%
|
20 558
-1%
|
21 793
+6%
|
21 630
-1%
|
21 711
+0%
|
22 535
+4%
|
23 461
+4%
|
23 776
+1%
|
21 347
-10%
|
20 837
-2%
|
21 684
+4%
|
23 541
+9%
|
27 375
+16%
|
29 288
+7%
|
29 201
0%
|
29 749
+2%
|
31 058
+4%
|
33 670
+8%
|
36 127
+7%
|
39 451
+9%
|
34 913
-12%
|
32 067
-8%
|
28 581
-11%
|
28 417
-1%
|
26 961
-5%
|
26 545
-2%
|
25 817
-3%
|
27 089
+5%
|
29 116
+7%
|
29 854
+3%
|
30 790
+3%
|
30 862
+0%
|
30 589
-1%
|
31 199
+2%
|
34 252
+10%
|
35 858
+5%
|
36 461
+2%
|
37 463
+3%
|
35 254
-6%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(2 605)
|
(2 456)
|
(2 380)
|
(2 386)
|
(2 425)
|
(2 428)
|
(2 461)
|
(2 434)
|
(2 369)
|
(2 282)
|
(2 235)
|
(2 242)
|
(2 274)
|
(2 295)
|
(2 159)
|
(2 180)
|
(1 833)
|
(1 767)
|
(1 589)
|
(1 251)
|
(13 987)
|
(14 460)
|
(19 766)
|
(20 684)
|
(10 496)
|
(15 348)
|
(12 828)
|
(13 296)
|
(6 983)
|
(5 620)
|
(3 333)
|
(2 141)
|
2 890
|
1 405
|
1 034
|
819
|
22 519
|
22 903
|
23 670
|
23 542
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(47)
|
0
|
(47)
|
(3 648)
|
0
|
0
|
0
|
85
|
0
|
0
|
0
|
0
|
0
|
(11)
|
(11)
|
(11)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(25)
|
(157)
|
(132)
|
0
|
(132)
|
0
|
(5)
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
19
|
19
|
21
|
3
|
(4)
|
(31)
|
(307)
|
(312)
|
(363)
|
0
|
(12)
|
(7)
|
(7)
|
0
|
(2)
|
(2)
|
(167)
|
(162)
|
(160)
|
(160)
|
(9)
|
0
|
0
|
0
|
|
| Total Other Income |
(11)
|
1
|
(66)
|
(248)
|
146
|
161
|
172
|
198
|
80
|
76
|
183
|
234
|
44
|
72
|
71
|
46
|
397
|
365
|
372
|
(656)
|
(623)
|
(614)
|
(551)
|
544
|
644
|
438
|
789
|
782
|
683
|
727
|
644
|
582
|
133
|
6
|
(17)
|
55
|
659
|
766
|
906
|
748
|
|
| Pre-Tax Income |
16 015
N/A
|
18 055
+13%
|
17 980
0%
|
19 159
+7%
|
19 219
+0%
|
19 444
+1%
|
20 240
+4%
|
21 225
+5%
|
21 493
+1%
|
19 141
-11%
|
18 785
-2%
|
19 676
+5%
|
21 311
+8%
|
25 154
+18%
|
27 202
+8%
|
27 086
0%
|
28 331
+5%
|
29 630
+5%
|
32 476
+10%
|
34 177
+5%
|
21 188
-38%
|
19 808
-7%
|
11 445
-42%
|
8 131
-29%
|
18 287
+125%
|
12 051
-34%
|
14 494
+20%
|
13 295
-8%
|
20 782
+56%
|
24 223
+17%
|
27 153
+12%
|
29 218
+8%
|
33 708
+15%
|
31 837
-6%
|
32 055
+1%
|
34 966
+9%
|
59 027
+69%
|
60 130
+2%
|
62 038
+3%
|
59 544
-4%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(3 150)
|
(3 516)
|
(3 483)
|
(3 743)
|
(4 057)
|
(4 131)
|
(4 318)
|
(4 545)
|
(4 710)
|
(4 144)
|
(5 115)
|
(5 313)
|
(5 490)
|
(6 451)
|
(5 717)
|
(5 720)
|
(6 393)
|
(6 614)
|
(7 388)
|
(6 205)
|
(4 321)
|
(4 335)
|
(2 209)
|
(2 941)
|
(5 373)
|
(4 050)
|
(5 242)
|
(5 160)
|
(5 821)
|
(6 234)
|
(6 431)
|
(6 764)
|
(5 564)
|
(6 221)
|
(5 446)
|
(6 149)
|
(15 039)
|
(15 168)
|
(12 554)
|
(11 955)
|
|
| Income from Continuing Operations |
12 864
|
14 539
|
14 497
|
15 416
|
15 162
|
15 314
|
15 922
|
16 680
|
16 783
|
14 997
|
13 671
|
14 364
|
15 821
|
18 703
|
21 484
|
21 365
|
21 938
|
23 015
|
25 088
|
27 972
|
16 867
|
15 473
|
9 235
|
5 190
|
12 914
|
8 002
|
9 252
|
8 135
|
14 961
|
17 989
|
20 722
|
22 454
|
28 144
|
25 616
|
26 609
|
28 817
|
43 988
|
44 962
|
49 485
|
47 589
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
12 864
N/A
|
14 539
+13%
|
14 497
0%
|
15 416
+6%
|
15 162
-2%
|
15 314
+1%
|
15 922
+4%
|
16 680
+5%
|
16 783
+1%
|
14 997
-11%
|
13 671
-9%
|
14 364
+5%
|
15 821
+10%
|
18 703
+18%
|
21 484
+15%
|
21 365
-1%
|
21 938
+3%
|
23 015
+5%
|
25 088
+9%
|
27 972
+11%
|
16 867
-40%
|
15 473
-8%
|
9 235
-40%
|
5 190
-44%
|
12 914
+149%
|
8 002
-38%
|
9 252
+16%
|
8 135
-12%
|
14 961
+84%
|
17 989
+20%
|
20 722
+15%
|
22 454
+8%
|
28 144
+25%
|
25 616
-9%
|
26 609
+4%
|
28 817
+8%
|
43 988
+53%
|
44 962
+2%
|
49 485
+10%
|
47 589
-4%
|
|
| EPS (Diluted) |
804
N/A
|
908.68
+13%
|
906.06
0%
|
963.5
+6%
|
947.62
-2%
|
957.12
+1%
|
995.12
+4%
|
1 042.5
+5%
|
1 048.93
+1%
|
937.31
-11%
|
854.43
-9%
|
897.75
+5%
|
988.81
+10%
|
1 168.93
+18%
|
1 342.75
+15%
|
1 335.31
-1%
|
1 371.12
+3%
|
1 438.43
+5%
|
1 568
+9%
|
1 748.25
+11%
|
1 054.18
-40%
|
977.21
-7%
|
589.44
-40%
|
332.44
-44%
|
828.84
+149%
|
513.57
-38%
|
597.5
+16%
|
525.36
-12%
|
966.21
+84%
|
1 161.72
+20%
|
1 338.21
+15%
|
1 450.07
+8%
|
1 817.55
+25%
|
1 654.3
-9%
|
1 718.41
+4%
|
1 860.99
+8%
|
2 840.74
+53%
|
2 903.66
+2%
|
3 195.76
+10%
|
3 073.31
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
